Discussing axSpA: Biologic therapy outcomes in axial spondyloarthritis
The IMID Forum
- Published
- May 15, 2026
- Duration
- 21:55
- Summary source
- description
- Last updated
- Jun 21, 2026
Discusses Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of…
Summary
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces anterior uveitis flares in high-risk axSpA and the effect of secukinumab dose escalation on MRI inflammation and damage in axSpA.
Intelligent report
Sign in to read teasers, or upgrade to Research Pro to commission a new dossier for this episode. Learn more →
Show notes
Join Dr Sofia Ramiro and Professor Atul Deodhar as they discuss the top publications in the world of axSpA. This month, the conversation covered how certolizumab pegol reduces anterior uveitis flares in high-risk axSpA and the effect of secukinumab dose escalation on MRI inflammation and damage in axSpA.